Flow cytometry analysis of protein expression profile of unmodified TMVs showed that TMVs express tumor and immune cell markers such as cancer stem cell markers (CD24 and CD44), co-stimulation (CD80 (B7-1)), immunosuppression (CD47, PD-L1), and innate immune cells (Gr1) (Figure 1A). This evidence concerns the gene CD47 and cancer.